Pathfinders in Biopharma
RBC Capital Markets
Categorias: Noticias y política
Añadir a Mi Lista
Escuchar el último episodio:
Innovation is surging in the U.S biotechnology sector, so why are investors still fearful about committing? Noël Brown, Head of U.S. Biotechnology Investment Banking at RBC Capital Markets, is joined by fund founders Craig Gordon, MD, CEO and CIO at GordonMD® Global Investments LP and Srini Akkaraju, MD, PhD, Managing Partner at Samsara BioCapital, to analyze the prospects for a full return of capital to the sector.
Episodios anteriores
-
46 - Unlocking Biotech’s Potential: Strategies for Navigating Public and Private Market InvestmentsFri, 22 Nov 2024 - 0h
-
45 - Former Investor Who Chose Broadcasting Over Biotech ETFsMon, 30 Sep 2024 - 0h
-
44 - Can AI Solve Molecule Mysteries that will Unlock Simpler Drug Discovery?Thu, 29 Aug 2024 - 0h
-
43 - Shots-on-Goal Licensing Company Aims for BreakthroughsFri, 19 Jul 2024 - 0h
-
42 - Why Biopharma Needs to Tell Better Stories on Novel DrugsThu, 11 Jul 2024 - 0h
-
41 - Venture capital velocity: What’s driving renewed momentum in biotech?Mon, 08 Jul 2024 - 0h
-
40 - Pharma Understands Phase One Data – But Does the Market?Fri, 21 Jun 2024 - 0h
-
39 - Davern Capital sees GLP-1 Opportunities Beyond ObesityFri, 14 Jun 2024 - 0h
-
38 - Betting on Healthcare’s Future Hits – and MissesMon, 10 Jun 2024 - 0h
-
37 - Innovation and an Aging Population Drive MedTechWed, 05 Jun 2024 - 0h
-
36 - Biopharma Investors See Opportunities in Targeted Treatments and Gene EditingMon, 03 Jun 2024 - 0h
-
35 - Biotech with a Mission to Target Unmet Cancer NeedsFri, 31 May 2024 - 0h
-
33 - The M&A Pool Set to Accelerate Biotech InnovationWed, 03 Apr 2024 - 0h
-
32 - How PIPEs finally unblocked biotech’s funding flowsFri, 29 Mar 2024 - 0h
-
31 - Disruptive Forces in Healthcare: Why HCIT is finally set to bounce backThu, 07 Mar 2024 - 0h
-
30 - Will the Biotech Rebound Run into Pricing Policy Obstacles?Tue, 27 Feb 2024 - 0h
-
29 - Few IPOs but plenty of follow-on for biotech in 2023Mon, 22 Jan 2024 - 0h
-
28 - U.S. Outlook: Will the US economy achieve a soft landing in 2024?Fri, 29 Dec 2023 - 0h
-
27 - Raising Venture Capital: A New Playbook for A New Era in BiotechWed, 22 Nov 2023 - 0h
-
26 - ECM: Robust End to Year, Despite Previous VolatilityTue, 31 Oct 2023 - 0h
-
25 - Biotech Halftime Report: A Winding Road AheadTue, 26 Sep 2023 - 0h
-
24 - The Urgent Need to Address the Youth Mental Health LandscapeThu, 17 Aug 2023 - 0h
-
23 - Website Traffic Reveals Biopharma Sales TrendsMon, 07 Aug 2023 - 0h
-
22 - When to Call it Quits: VCs Making Tough Decisions in a Tough MarketThu, 13 Jul 2023 - 0h
-
21 - How Biotech M&A is Redefining the Strategic LandscapeFri, 23 Jun 2023 - 0h
-
20 - Healthcare Should Get Ready for ‘Fast and Furious’ M&AThu, 08 Jun 2023 - 0h
-
19 - Innovation and Growth: Key Ingredients to Healthcare M&AWed, 07 Jun 2023 - 0h
-
18 - Biotech M&A Booms, But Have Buyouts Reached a Tipping Point?Fri, 02 Jun 2023 - 0h
-
17 - Global Blood Therapeutics Commitment to Sickle-Cell InnovationMon, 22 May 2023 - 0h
-
16 - Is This the Breakthrough Moment for Genetic Medicine?Thu, 13 Apr 2023 - 0h
-
15 - The Hidden Revolution Set to Turn US Healthcare on its HeadThu, 26 Jan 2023 - 0h
-
14 - The Big Picture for BiotechTue, 13 Dec 2022 - 0h
-
13 - Why Biopharma Investment Requires a Different MindsetTue, 22 Nov 2022 - 0h
-
12 - The Optimism Behind the Biopharma MarketMon, 03 Oct 2022 - 0h
-
11 - Biotech Investors: How to Find Value in a Bear MarketMon, 21 Mar 2022 - 0h
-
10 - A call to action: Global Blood Therapeutics on tackling orphan diseaseWed, 08 Dec 2021 - 0h
-
9 - Ionis: Raising The Bar For ESGThu, 28 Oct 2021 - 0h
-
8 - Biotech and Big Pharma: Blueprint for Successful PartnershipThu, 30 Sep 2021 - 0h
-
7 - What’s Material in ESG for Biopharma Firms?Tue, 04 May 2021 - 0h
-
6 - Inside Track: Behind the Scenes of a Major Biotech SPACMon, 26 Apr 2021 - 0h
-
5 - Biotech SPACs: A new route to going publicFri, 12 Mar 2021 - 0h
-
4 - Vida Ventures: Powering Breakthroughs in BiopharmaMon, 21 Dec 2020 - 0h
-
3 - 5AM Ventures: Fueling the Next Generation of InnovatorsMon, 21 Dec 2020 - 0h
-
2 - Biotech IPOs: Navigating the New LandscapeThu, 10 Dec 2020 - 0h
-
1 - Biotech IPOs: New Steps to Success on the Road to Going PublicTue, 01 Dec 2020 - 0h
Mostrar más episodios
5
